Literature DB >> 16250040

Risk factors and comorbidities in primary biliary cirrhosis: a controlled interview-based study of 1032 patients.

M Eric Gershwin1, Carlo Selmi, Howard J Worman, Ellen B Gold, Mitchell Watnik, Jessica Utts, Keith D Lindor, Marshall M Kaplan, John M Vierling.   

Abstract

Primary biliary cirrhosis (PBC) is an autoimmune disease of unknown etiology, often associated with other autoimmune conditions. Controlled studies have so far provided conflicting data on risk factors and comorbidity rates in PBC. We enrolled patients with PBC (n = 1032) from 23 tertiary referral centers for liver diseases in the United States and random-digit-dialed controls (n = 1041) matched for sex, age, race, and geographical location. Patients and controls were administered a modified version of the US National Health and Nutrition Examination Study (NHANES III) questionnaire by trained personnel to evaluate associations between PBC and social, demographic, personal and family medical histories, lifestyle, and reproductive factors and the rates of comorbidity in affected individuals. Data indicate that having a first-degree relative with PBC (adjusted odds ratio [AOR] 10.736; 95% confidence interval 4.227-27.268), history of urinary tract infections (AOR 1.511, 95% CI 1.192-1.915), past smoking (AOR 1.569, 95% CI 1.292-1.905), or use of hormone replacement therapies (AOR 1.548, 95% CI 1.273-1.882) were significantly associated with increased risk of PBC. The frequent use of nail polish slightly increased the risk of having PBC. Other autoimmune diseases were found in 32% of cases and 13% of controls (P<0.0001). In conclusion, environmental factors, possibly including infectious agents through urinary tract infections or chemicals contained in cigarette smoke, may induce PBC in genetically susceptible individuals. Exogenous estrogens may also contribute to explain the female predominance of the disease.

Entities:  

Mesh:

Year:  2005        PMID: 16250040      PMCID: PMC3150736          DOI: 10.1002/hep.20907

Source DB:  PubMed          Journal:  Hepatology        ISSN: 0270-9139            Impact factor:   17.425


  38 in total

1.  Staging of chronic nonsuppurative destructive cholangitis (syndrome of primary biliary cirrhosis).

Authors:  J Ludwig; E R Dickson; G S McDonald
Journal:  Virchows Arch A Pathol Anat Histol       Date:  1978-08-22

2.  Features of Sjögren's syndrome in patients with primary biliary cirrhosis.

Authors:  P Uddenfeldt; A Danielsson; A Forssell; M Holm; Y Ostberg
Journal:  J Intern Med       Date:  1991-11       Impact factor: 8.989

3.  Increased incidence of menstrual abnormalities and hysterectomy preceding primary biliary cirrhosis.

Authors:  A J Stellon; R Williams
Journal:  Br Med J (Clin Res Ed)       Date:  1986-08-02

4.  Development of epidemiologic tools for measuring environmental tobacco smoke exposure.

Authors:  J Coghlin; S K Hammond; P H Gann
Journal:  Am J Epidemiol       Date:  1989-10       Impact factor: 4.897

5.  Random digit dialing in selecting a population-based control group.

Authors:  P Hartge; L A Brinton; J F Rosenthal; J I Cahill; R N Hoover; J Waksberg
Journal:  Am J Epidemiol       Date:  1984-12       Impact factor: 4.897

6.  Comparing dietary recall data for mothers and children obtained on two occasions in a case-control study of environmental factors and childhood brain tumours.

Authors:  J R Wilkins; J Y Bunn
Journal:  Int J Epidemiol       Date:  1997-10       Impact factor: 7.196

7.  In situ nucleic acid hybridization of cytokines in primary biliary cirrhosis: predominance of the Th1 subset.

Authors:  K Harada; J Van de Water; P S Leung; R L Coppel; A Ansari; Y Nakanuma; M E Gershwin
Journal:  Hepatology       Date:  1997-04       Impact factor: 17.425

8.  Effect of estradiol upon serum enzymes in primary biliary cirrhosis.

Authors:  J M Guattery; W W Faloon
Journal:  Hepatology       Date:  1987 Jul-Aug       Impact factor: 17.425

9.  M2 mitochondrial antibodies and urinary rough mutant bacteria in patients with primary biliary cirrhosis and in patients with recurrent bacteriuria.

Authors:  P Butler; F Valle; J M Hamilton-Miller; W Brumfitt; H Baum; A K Burroughs
Journal:  J Hepatol       Date:  1993-03       Impact factor: 25.083

10.  Incidence of hepatic and extra-hepatic malignancies in primary biliary cirrhosis (PBC).

Authors:  A Floreani; M R Biagini; M Chiaramonte; S Milani; C Surrenti; R Naccarato
Journal:  Ital J Gastroenterol       Date:  1993 Nov-Dec
View more
  174 in total

Review 1.  Gender differences in autoimmunity associated with exposure to environmental factors.

Authors:  K Michael Pollard
Journal:  J Autoimmun       Date:  2011-12-03       Impact factor: 7.094

Review 2.  Primary biliary cirrhosis in a rheumatoid arthritis patient treated with rituximab, a case-based review.

Authors:  Joaquim Polido-Pereira; Ana Maria Rodrigues; Helena Canhão; Fernando Saraiva; José Alberto Pereira da Silva; João Eurico Fonseca
Journal:  Clin Rheumatol       Date:  2011-10-26       Impact factor: 2.980

Review 3.  Epidemiology of environmental exposures and human autoimmune diseases: findings from a National Institute of Environmental Health Sciences Expert Panel Workshop.

Authors:  Frederick W Miller; Lars Alfredsson; Karen H Costenbader; Diane L Kamen; Lorene M Nelson; Jill M Norris; Anneclaire J De Roos
Journal:  J Autoimmun       Date:  2012-06-25       Impact factor: 7.094

4.  The multiple autoimmune syndromes. A clue for the autoimmune tautology.

Authors:  Juan-Manuel Anaya; John Castiblanco; Adriana Rojas-Villarraga; Ricardo Pineda-Tamayo; Roger A Levy; José Gómez-Puerta; Carlos Dias; Ruben D Mantilla; Juan Esteban Gallo; Ricard Cervera; Yehuda Shoenfeld; Mauricio Arcos-Burgos
Journal:  Clin Rev Allergy Immunol       Date:  2012-12       Impact factor: 8.667

5.  Identification of new autoantigens for primary biliary cirrhosis using human proteome microarrays.

Authors:  Chao-Jun Hu; Guang Song; Wei Huang; Guo-Zhen Liu; Chui-Wen Deng; Hai-Pan Zeng; Li Wang; Feng-Chun Zhang; Xuan Zhang; Jun Seop Jeong; Seth Blackshaw; Li-Zhi Jiang; Heng Zhu; Lin Wu; Yong-Zhe Li
Journal:  Mol Cell Proteomics       Date:  2012-05-30       Impact factor: 5.911

Review 6.  Primary biliary cirrhosis: From bench to bedside.

Authors:  Elias Kouroumalis; George Notas
Journal:  World J Gastrointest Pharmacol Ther       Date:  2015-08-06

Review 7.  Overcoming a "probable" diagnosis in antimitochondrial antibody negative primary biliary cirrhosis: study of 100 sera and review of the literature.

Authors:  Nicola Bizzaro; Giovanni Covini; Floriano Rosina; Paolo Muratori; Elio Tonutti; Danilo Villalta; Fiorenza Pesente; Maria Grazia Alessio; Marilina Tampoia; Antonio Antico; Stefan Platzgummer; Brunetta Porcelli; Lucia Terzuoli; Marco Liguori; Danila Bassetti; Ignazio Brusca; Piero L Almasio; Giuseppe Tarantino; Chiara Bonaguri; Paolo Agostinis; Elena Bredi; Renato Tozzoli; Pietro Invernizzi; Carlo Selmi
Journal:  Clin Rev Allergy Immunol       Date:  2012-06       Impact factor: 8.667

8.  Epigenetics in the Primary Biliary Cholangitis and Primary Sclerosing Cholangitis.

Authors:  Angela C Cheung; Nicholas F LaRusso; Gregory J Gores; Konstantinos N Lazaridis
Journal:  Semin Liver Dis       Date:  2017-05-31       Impact factor: 6.115

9.  Familial clustering and genetic background of primary biliary cirrhosis in Japan.

Authors:  Masatoshi Yanagisawa; Hitoshi Takagi; Hitomi Takahashi; Masahiro Uehara; Toshiyuki Otsuka; Kazuhisa Yuasa; Kenichi Hosonuma; Masatomo Mori
Journal:  Dig Dis Sci       Date:  2009-12-11       Impact factor: 3.199

10.  Questionnaire based assessment of risk factors for primary biliary cirrhosis.

Authors:  Craig Lammert; Douglas L Nguyen; Brian D Juran; Erik Schlicht; Joseph J Larson; Elizabeth J Atkinson; Konstantinos N Lazaridis
Journal:  Dig Liver Dis       Date:  2013-03-11       Impact factor: 4.088

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.